Cronos Group Inc. (CRON)
| Market Cap | 1.02B |
| Revenue (ttm) | 146.59M |
| Net Income (ttm) | -9.45M |
| Shares Out | 379.05M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | 40.65 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 759,000 |
| Open | 2.670 |
| Previous Close | 2.700 |
| Day's Range | 2.630 - 2.700 |
| 52-Week Range | 1.780 - 3.430 |
| Beta | 1.21 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 11, 2026 |
About CRON
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada. [Read more]
Financial Performance
Financial StatementsNews
'GIANT STEP FORWARD': Reclassification of medical cannabis lauded
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.' 00:00 Introduction & Re...
Cronos Group (CRON) Sees Decline After Initial Surge on Marijuana Rescheduling News
Cronos Group (CRON) Sees Decline After Initial Surge on Marijuana Rescheduling News
'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled from a Schedule I drug to the less stric...
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling Food and Drug Administration-approved and state-licensed medical cannabis products as a...
Cannabis rescheduling fuels optimism across industry
The U.S. Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as less dangerous in one of the biggest changes t...
Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know
Akanda Corp. (NASDAQ: AKAN) shares are trending on Thursday. AKAN shares climbed 33.69% to $13.65 after the bell on Wednesday. The after-hours gain follows a 214.15% surge during the regular session,...
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe cou...
Trump To Reclassify Marijuana 'As Soon As Wednesday,' But Prediction Markets Are Skeptical
Cannabis stocks ripped today on an Axios scoop that President Donald Trump will move to reclassify marijuana as soon as this week. Tilray Brands (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC) and Crono...
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 a...
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
Marijuana stock investors are still in a position where volatility and speculation control the outcome. Especially with all the laws and regulatory changes that have transformed the cannabis industry....
3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026
The Canadian cannabis sector continues to evolve in 2026, even as volatility remains elevated. Total Canadian cannabis sales have steadily increased in recent years, showing consistent demand growth. ...
Top Canadian Marijuana Stocks To Watch This Month For Better Trading
The cannabis industry has made a tremendous impact on the world. From being once a taboo subject to now a well-respected and much more accepted industry. Even the thought of what may happen to a legal...
Cronos Group Transcript: The 38th Annual Roth Conference
Canadian supply has shifted from oversupply to shortage, prompting a focus on quality and efficiency. Brand success is driven by consumer-centric innovation, while operational expansion and disciplined capital deployment support growth. Internationally, regulatory certainty and market maturity guide investment, with the Netherlands and Israel highlighted as key markets.
Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands
The global cannabis industry continues evolving as legalization slowly expands across multiple regions. Investors remain focused on companies positioned for long-term growth. Canadian cannabis produce...
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight
Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
Q4 2025 Cronos Group Inc Earnings Call Transcript
Q4 2025 Cronos Group Inc Earnings Call Transcript
Cronos Group Earnings Call Transcript: Q4 2025
Record 2025 results with 25% organic net revenue growth, strong Canadian and international performance, and robust cash position. Acquisition of CanAdelaar expands European footprint, while guidance calls for stable gross margins and disciplined capital allocation.
Cronos Group Earnings Review: Q4 Summary
The earnings results for Cronos Group (NASDAQ: CRON) for Q4 were made public on Thursday, February 26, 2026 at 07:35 AM. Here's a comprehensive overview of the announcement. Earnings Cronos Group mis...
Insights into Cronos Group Q4 Earnings
Cronos Group (NASDAQ: CRON) released its Q4 earnings on Thursday, February 26, 2026 at 07:35 AM. Here's what's important from the earnings announcement. Earnings Cronos Group missed estimated earning...
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million ; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million
Are Canadian Cannabis Stocks Ready to Rebound? 3 Names to Watch
The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum...
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™
Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds Spinach PUFFERZ™ delivers a flavorful experience combining h...
3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026
What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural in...
Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday...